X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC LTD Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD Quarterly Results   (ALMC)

Here are the latest quarterly results of ALEMBIC LTD. For more details, see the ALEMBIC LTD financial fact sheet and ALEMBIC LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

ALEMBIC LTD Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
*
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m349382259270298504306329 
Other income Rs m324769112451130 
Turnover Rs m352629264279309749316359 
Expenses Rs m305319313273282523295313 
Gross profit Rs m4563-54-316-201117 
Depreciation Rs m1414102413131313 
Interest Rs m00001110 
Profit before tax Rs m33296-58-1814212833 
Tax Rs m821-19-40-1415 
Profit after tax Rs m26275-39-1414226728 
Gross profit margin %12.816.6-21.0-1.25.3-3.93.45.0 
Effective tax rate %23.07.232.421.9-0.7-6.69.314.5 
Net profit margin %7.371.9-15.2-5.34.644.92.28.6 
Diluted EPS Rs 0.0 0.5 -0.1 0.0 0.0 0.4 0.0 0.1  
Diluted EPS (TTM) Rs 0.4 0.6 0.5 0.4 0.4 0.3 0.4 0.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare ALEMBIC LTD With:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; IT Stocks Rally(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day and ended the day in red.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Why India is Short of Cash Again(Vivek Kaul's Diary)

Apr 19, 2018

It is basically a supply problem with not enough currency going around in the financial system.

A Sure Shot Way to Predict a Multibagger Stock(The 5 Minute Wrapup)

Apr 17, 2018

The imaginary stock price of IIM Ahmedabad could have rivalled the returns from Titan and Asian Paints thanks to its enormous pricing power.

Why Buffett Would Scowl at My Latest Recommendation...(Profit Hunter)

Apr 18, 2018

Warren Buffett's advice that may not be so relevant in these dynamic times, and could do investors more damage than good when taken at the face value.

This is How a Smart Robo-Advisor can Help You Chart Your Asset Allocation...(Outside View)

Apr 16, 2018

PersonalFN explains how a dependable robo-advisory platform can help you create your personalized asset allocation plan

How Retail Investors Often Dump the Best Buying Opportunities(Chart Of The Day)

Apr 16, 2018

A journey into how retail investors have invested since the turn of the millennium and why I don't want to do repeat that mistake ever again...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Apr 25, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC LTD

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS